Q&A With David Holtzman, MD, FAAN: Screening for Alzheimer's Before Symptoms Develop

One of the main focus points in the treatment of Alzheimer's Disease is screening patients before they even show symptoms of the condition. This is a part of the process that also includes looking to develop new treatments that could be used in the future.

David Holtzman, MD, FAAN, from the George Washington University School of Medicine discussed how the screening process works, what the test looks for, and what it can mean for finding future treatments during the American Academy of Neurology's annual meeting in Washington DC.